Dataset Information


A Novel de novo Mutation in CEACAM16 Associated with Postlingual Hearing Impairment.

ABSTRACT: Mutations in CEACAM16 cause autosomal dominant nonsyndromic hearing loss (DFNA4B). So far, 2 families have been reported with segregating missense mutations, both in the immunoglobulin constant domain A of the CEACAM16 protein. In this study, we used the TruSight One panel to investigate a parent-child trio without familial history of hearing loss and one affected child. When filtering for recessive inheritance and de novo events, we discovered a de novo CEACAM16 mutation (c.1094T>G, p.Leu365Arg) as the sole likely pathogenic variant. The de novo mutation was confirmed by Sanger sequencing and STR analysis. The proband's hearing loss closely matches the described onset and severity for DFNA4B. We present the third CEACAM16 variant and the first de novo mutation in CEACAM16. This de novo mutation is robustly described as a pathogenic mutation according to in silico mutation prediction tools and affects a highly conserved amino acid in the most strongly conserved CEACAM16 N2 domain. Our strategy of screening family trios enhances de novo mutation discovery and the exclusion of other variants of potential interest through pedigree filtering.

SUBMITTER: Hofrichter MA 

PROVIDER: S-EPMC4662267 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3381124 | BioStudies
2015-01-01 | S-EPMC4375019 | BioStudies
2019-01-01 | S-EPMC6582249 | BioStudies
2018-01-01 | S-EPMC6060001 | BioStudies
1000-01-01 | S-EPMC3054008 | BioStudies
2020-01-01 | S-EPMC7434732 | BioStudies
2016-01-01 | S-EPMC4922063 | BioStudies
2018-01-01 | S-EPMC5983957 | BioStudies
2021-01-01 | S-EPMC7944167 | BioStudies
2014-01-01 | S-EPMC4063943 | BioStudies